Clinical Trial Update: Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of Ulixertinib and Palbociclib in patients with advanced pancreatic cancer and other solid tumors; recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Pancreatic Cancer

Drugs mentioned

• IBRANCE (PALBOCICLIB)
• Ulixertinib (ulixertinib)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Tumor, Solid, Pancreatic Cancer | Phase 1 | Status: RECRUITING